Kidney function and lithium concentrations of rats given an injection of lithium orotate or lithium carbonate

@article{Smith1979KidneyFA,
  title={Kidney function and lithium concentrations of rats given an injection of lithium orotate or lithium carbonate},
  author={D. F. Smith and Mogens Schou},
  journal={Journal of Pharmacy and Pharmacology},
  year={1979},
  volume={31}
}
  • D. Smith, M. Schou
  • Published 1 September 1979
  • Psychology, Medicine
  • Journal of Pharmacy and Pharmacology
A recent study by Kling et al (1978) noted the finding of higher lithium concentrations in serum and brain of rats after an intraperitoneal injection (2 mmol lithium kg−1) of lithium orotate as a slurry than of lithium carbonate in solution. The authors suggested that lithium orotate might offer advantages in the treatment of patients. We repeated the experiments of Kling et al but in addition examined the kidney function of the rats. Glomerular filtration rate and urine flow were markedly… 
Lithium orotate is more potent, effective, and less toxic than lithium carbonate in a mouse model of mania
TLDR
LiOr demonstrates superior efficacy, potency, and tolerability to LiCO in both male and female mice as a result of select transport-mediated uptake.
A Toxicological Evaluation of Lithium Orotate.
Lithium toxicity from an internet dietary supplement
TLDR
An 18-year-old woman presented to an emergency department after ingesting 18 tablets of Find Serenity Now®, and was subsequently transferred to a psychiatric hospital for further care.
Lithium concentration and clinical responses.
TLDR
In a pilot study it is shown that the plasma lithium concentration can be raised from 0 to 2 mmol/l in a few hours, inducing changes in both kidney function and neuropsychological tests after only short delay, suggesting that mania might be quickly controlled with rapid dosage and opens up a new way of analysing the mechanisms of lithium action.
A Review for Lithium: Pharmacokinetics, Drug Design and Toxicity.
TLDR
Various formulations of lithium have potential for treating neurodegenerative brain diseases but further study on their pharmacokinetics will be required in order to determine the optimal formulation, dosage and route of administration.
Lithium orotate: A superior option for lithium therapy?
TLDR
This review addresses the controversial history of LiOr and proposes LiOr, a compound largely abandoned since the late 1970s, proposed to cross the blood-brain barrier and enter cells more readily than Li2 CO3, which will theoretically allow for reduced dosage requirements and ameliorated toxicity concerns.
Estimation of Bioavailability on a Single Occasion After Semisimultaneous Drug Administration
TLDR
The estimation of bioavailability was robust with respect to the choice of absorption and disposition model and the duration of sampling, and the precision was better in the latter than in the traditional method.
Poor Diet, Stress, and Inactivity Converge to Form a “Perfect Storm” That Drives Alzheimer’s Disease Pathogenesis
TLDR
It is concluded that lifestyle and environmental factors likely contribute to AD pathogenesis and that simple lifestyle and dietary changes can help counteract their effects.
Bipolar disorder and eating disorders in sport: a case of comorbidity and review of treatment principles in an elite athlete
TLDR
Treatment guidelines that increasingly take into consideration complex psychiatric comorbidities and nuanced pharmacologic approaches are needed in order to advance the field of sports psychiatry.
...
...

References

SHOWING 1-3 OF 3 REFERENCES
LITHIUM OROTATE, CARBONATE AND CHLORIDE: PHARMACOKINETICS, POLYDIPSIA AND POLYURIA IN RATS
  • D. Smith
  • Psychology, Materials Science
  • 1976
1 The pharmacokinetics of the lithium ion administered as lithium orotate were studied in rats. Parallel studies were carried out with lithium carbonate and lithium chloride. 2 No differences in the
Rat brain and serum lithium concentrations after acute injections of lithium carbonate and orotate
TLDR
The possibility that lower doses of lithium orotate than lithium carbonate may achieve therapeutic brain lithium concentrations and relatively stable serum concentrations is suggested.
Carl Petersens Fund and The Danish Medical Research Council provided financial support. Lithium orotate was supplied by Nadrol-Chemie